e03015f06f
- Source: inbox/queue/2025-12-12-utmb-uthealth-texas-ibogaine-impact-50m-oud.md - Domain: health - Claims: 2, Entities: 1 - Enrichments: 2 - Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5) Pentagon-Agent: Vida <PIPELINE>
18 lines
2.4 KiB
Markdown
18 lines
2.4 KiB
Markdown
---
|
|
type: claim
|
|
domain: health
|
|
description: Texas authorized $50M for ibogaine research through veteran-focused framing (Stanford n=30 study in veterans) where psilocybin depression research might have failed politically
|
|
confidence: experimental
|
|
source: Texas SB 2308 (December 2025), Trump EO April 2026 directing ARPA-H funding toward ibogaine for veterans
|
|
created: 2026-05-11
|
|
title: Conservative state psychedelic research authorization is enabled by veteran constituency that transcends partisan politics rather than general mental health advocacy
|
|
agent: vida
|
|
sourced_from: health/2025-12-12-utmb-uthealth-texas-ibogaine-impact-50m-oud.md
|
|
scope: structural
|
|
sourcer: UTMB Health / UTHealth Houston
|
|
related: ["psilocybin-achieves-positive-phase3-trd-single-dose-26week-durability", "ibogaine-federal-policy-priority-rests-on-single-n30-pilot-illustrating-veteran-constituency-acceleration-ahead-of-evidence-hierarchy", "stanford-ibogaine-veterans-study", "trump-2026-psychedelic-executive-order-creates-bipartisan-regulatory-acceleration-through-existing-frameworks"]
|
|
---
|
|
|
|
# Conservative state psychedelic research authorization is enabled by veteran constituency that transcends partisan politics rather than general mental health advocacy
|
|
|
|
Texas represents the most conservative large state in the US, yet authorized $50M for Schedule I psychedelic drug research through SB 2308 in December 2025, with potential $50M federal ARPA-H match directed by Trump executive order in April 2026. The political enabling mechanism is veteran-specific: the Stanford 2024 study (n=30) demonstrated 88% PTSD reduction and 87% depression reduction in veterans specifically, and the Texas IMPACT consortium explicitly targets PTSD and TBI alongside OUD. Veterans represent a constituency that transcends partisan politics in ways that general mental health populations do not. The PTSD+TBI+veteran framing made ibogaine acceptable to Texas Republicans where psilocybin for depression in general populations likely would not have secured equivalent funding. This creates a distinct political pathway for psychedelic research: veteran-focused applications can access conservative state funding and federal support (Trump EO) that wellness or general mental health applications cannot. The Trump administration's ARPA-H directive and DEA rescheduling commitment upon Phase 3 completion further demonstrates bipartisan federal support when framed through veteran health rather than broader mental health reform.
|